These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 23717682)
1. An enzyme-generated fragment of tau measured in serum shows an inverse correlation to cognitive function. Henriksen K; Wang Y; Sørensen MG; Barascuk N; Suhy J; Pedersen JT; Duffin KL; Dean RA; Pajak M; Christiansen C; Zheng Q; Karsdal MA PLoS One; 2013; 8(5):e64990. PubMed ID: 23717682 [TBL] [Abstract][Full Text] [Related]
2. Stress hormone leads to memory deficits and altered tau phosphorylation in a model of Alzheimer's disease. Joshi YB; Chu J; Praticò D J Alzheimers Dis; 2012; 31(1):167-76. PubMed ID: 22531419 [TBL] [Abstract][Full Text] [Related]
3. S100A7, a novel Alzheimer's disease biomarker with non-amyloidogenic alpha-secretase activity acts via selective promotion of ADAM-10. Qin W; Ho L; Wang J; Peskind E; Pasinetti GM PLoS One; 2009; 4(1):e4183. PubMed ID: 19159013 [TBL] [Abstract][Full Text] [Related]
4. Relationship between serum levels of tau fragments and clinical progression of Alzheimer's disease. Henriksen K; Byrjalsen I; Christiansen C; Karsdal MA J Alzheimers Dis; 2015; 43(4):1331-41. PubMed ID: 25171717 [TBL] [Abstract][Full Text] [Related]
5. Serum Fragments of Tau for the Differential Diagnosis of Alzheimer's Disease. Inekci D; Henriksen K; Linemann T; Karsdal MA; Habib A; Bisgaard C; Eriksen FB; Vilholm OJ Curr Alzheimer Res; 2015; 12(9):829-36. PubMed ID: 26159200 [TBL] [Abstract][Full Text] [Related]
6. Unfolded protein response signaling by transcription factor XBP-1 regulates ADAM10 and is affected in Alzheimer's disease. Reinhardt S; Schuck F; Grösgen S; Riemenschneider M; Hartmann T; Postina R; Grimm M; Endres K FASEB J; 2014 Feb; 28(2):978-97. PubMed ID: 24165480 [TBL] [Abstract][Full Text] [Related]
7. Serum Tau Proteins as Potential Biomarkers for the Assessment of Alzheimer's Disease Progression. Nam E; Lee YB; Moon C; Chang KA Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32679907 [TBL] [Abstract][Full Text] [Related]
8. Berberine ameliorates β-amyloid pathology, gliosis, and cognitive impairment in an Alzheimer's disease transgenic mouse model. Durairajan SS; Liu LF; Lu JH; Chen LL; Yuan Q; Chung SK; Huang L; Li XS; Huang JD; Li M Neurobiol Aging; 2012 Dec; 33(12):2903-19. PubMed ID: 22459600 [TBL] [Abstract][Full Text] [Related]
9. ADAM10 plasma levels predict worsening in cognition of older adults: a 3-year follow-up study. Oliveira Monteiro MPA; Salheb Oliveira DSM; Manzine PR; Crispim Nascimento CM; Dos Santos Orlandi AA; de Oliveira Gomes GA; Dos Santos Orlandi F; Zazzetta MS; Pott-Junior H; Cominetti MR Alzheimers Res Ther; 2021 Jan; 13(1):18. PubMed ID: 33419480 [TBL] [Abstract][Full Text] [Related]
10. ADAM10 Plasma and CSF Levels Are Increased in Mild Alzheimer's Disease. Pereira Vatanabe I; Peron R; Mantellatto Grigoli M; Pelucchi S; De Cesare G; Magalhães T; Manzine PR; Figueredo Balthazar ML; Di Luca M; Marcello E; Cominetti MR Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33670873 [TBL] [Abstract][Full Text] [Related]
11. MicroRNA-144 is regulated by activator protein-1 (AP-1) and decreases expression of Alzheimer disease-related a disintegrin and metalloprotease 10 (ADAM10). Cheng C; Li W; Zhang Z; Yoshimura S; Hao Q; Zhang C; Wang Z J Biol Chem; 2013 May; 288(19):13748-61. PubMed ID: 23546882 [TBL] [Abstract][Full Text] [Related]
12. Two novel blood-based biomarker candidates measuring degradation of tau are associated with dementia: A prospective study. Neergaard JS; Dragsbæk K; Christiansen C; Karsdal MA; Brix S; Henriksen K PLoS One; 2018; 13(4):e0194802. PubMed ID: 29641555 [TBL] [Abstract][Full Text] [Related]
13. Stimulation of non-amyloidogenic processing of amyloid-β protein precursor by cryptotanshinone involves activation and translocation of ADAM10 and PKC-α. Durairajan SS; Liu LF; Lu JH; Koo I; Maruyama K; Chung SK; Huang JD; Li M J Alzheimers Dis; 2011; 25(2):245-62. PubMed ID: 21403388 [TBL] [Abstract][Full Text] [Related]
14. Inverse association of cortisol serum levels with T-tau, P-tau 181 and P-tau 231 peptide levels and T-tau/Abeta 1-42 ratios in CSF in patients with mild Alzheimer's disease dementia. Laske C; Stransky E; Fritsche A; Eschweiler GW; Leyhe T Eur Arch Psychiatry Clin Neurosci; 2009 Mar; 259(2):80-5. PubMed ID: 18806919 [TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein E-mediated Modulation of ADAM10 in Alzheimer's Disease. Shackleton B; Crawford F; Bachmeier C Curr Alzheimer Res; 2017; 14(6):578-585. PubMed ID: 28164773 [TBL] [Abstract][Full Text] [Related]
17. Platelet a disintegrin and metallopeptidase 10 expression correlates with clock drawing test scores in Alzheimer's disease. Manzine PR; Barham EJ; Vale FA; Selistre-de-Araújo HS; Pavarini SC; Cominetti MR Int J Geriatr Psychiatry; 2014 Apr; 29(4):414-20. PubMed ID: 23970375 [TBL] [Abstract][Full Text] [Related]
18. The Role of ADAM10 in Alzheimer's Disease. Yuan XZ; Sun S; Tan CC; Yu JT; Tan L J Alzheimers Dis; 2017; 58(2):303-322. PubMed ID: 28409746 [TBL] [Abstract][Full Text] [Related]
19. A novel blood-brain barrier co-culture system for drug targeting of Alzheimer's disease: establishment by using acitretin as a model drug. Freese C; Reinhardt S; Hefner G; Unger RE; Kirkpatrick CJ; Endres K PLoS One; 2014; 9(3):e91003. PubMed ID: 24608847 [TBL] [Abstract][Full Text] [Related]
20. Endocytosis of synaptic ADAM10 in neuronal plasticity and Alzheimer's disease. Marcello E; Saraceno C; Musardo S; Vara H; de la Fuente AG; Pelucchi S; Di Marino D; Borroni B; Tramontano A; Pérez-Otaño I; Padovani A; Giustetto M; Gardoni F; Di Luca M J Clin Invest; 2013 Jun; 123(6):2523-38. PubMed ID: 23676497 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]